DEF: AYRO, Inc. Proposes Share Increase and Reverse Stock Split at 2025 Annual Meeting

AYRO, Inc. is seeking stockholder approval for a share increase and a reverse stock split at its upcoming 2025 Annual Meeting to enhance financial flexibility and maintain Nasdaq listing.

Summary

• AYRO, Inc. is holding its 2025 Annual Meeting of Stockholders virtually on May 19, 2025.
• The meeting will address several key proposals, including the election of six directors, an increase in authorized shares of Common Stock, ratification of the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm, a reverse stock split, and a proposal to adjourn the meeting if necessary.
• The company proposes to increase the number of authorized shares of Common Stock from 200,000,000 to 1,200,000,000.
• The company is also seeking approval for a reverse stock split at a ratio ranging from 1-for-2 to 1-for-100, to be determined by the Board.
• The Board recommends voting FOR all proposals.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining proposals for the annual meeting. While the reverse stock split suggests potential challenges, the overall tone is neutral and focused on maintaining compliance and flexibility.

Positives

• The proposed share increase provides the company with greater flexibility to pursue financing and corporate opportunities.
• The reverse stock split aims to increase the per share market price of the Common Stock to meet Nasdaq's minimum bid price requirement, potentially attracting a broader range of investors.
• Virtual annual meetings enable greater stockholder attendance and participation, improve meeting efficiency, and reduce costs and environmental impact.

Negatives

• If the share increase proposal is not approved, the company may be limited in its ability to issue additional shares for equity incentives, capital raising, or strategic transactions.
• The reverse stock split may not increase the price of the Common Stock over the long term and could decrease liquidity.
• The reverse stock split could result in some stockholders owning odd lots, which may be more difficult to sell.

Risks

• Failure to obtain stockholder approval for the share increase or reverse stock split could limit the company's financial flexibility and strategic options.
• The reverse stock split may not be successful in maintaining Nasdaq listing compliance.
• The market price of the Common Stock may be affected by factors unrelated to the number of shares outstanding, such as the company's business and financial performance.

Future Outlook

The company aims to use the increased authorized shares for future financing and corporate opportunities. The reverse stock split is intended to maintain Nasdaq listing compliance and potentially attract more investors.

Management Comments

• Joshua Silverman, Executive Chairman, urges stockholders to submit their proxies as soon as possible.
• The Board believes that the proposed actions are in the best interests of the company and its stockholders.

Industry Context

Companies often use reverse stock splits to meet minimum listing requirements of exchanges like Nasdaq. Increasing authorized shares is a common practice to provide flexibility for future capital raising and strategic transactions.

Comparison to Industry Standards

• Reverse stock splits are a common tool for companies facing delisting from exchanges like Nasdaq, as seen with companies like Marker Therapeutics, Inc. who Mr. Silverman previously served as a director.
• Increasing authorized shares is a standard corporate practice, comparable to actions taken by companies like MYMD Pharmaceuticals, Inc. and Petros Pharmaceutical, Inc., where Mr. Silverman serves as a director, to ensure sufficient shares for future growth and financing.

Related Party Transactions

• Beginning August 2024, Gilbert Villarreal, the president of AYRO Operating Company, Inc., through GLV Ventures and Electric Power, entities owned and controlled by Mr. Villarreal, has been providing consulting services to the Company in connection with the reengineering of the Companys Vanish at a rate of $30,000 per month.
• As of December 31, 2024, the Company has paid Mr. Villarreal an aggregate of $270,325 for such services performed, which is in addition to the compensation paid to Mr. Villarreal as President of AYRO Operating Company, Inc.
• In connection with the Private Placement, the Company received investments of (i) $14.0 million from affiliates of Mr. Abbe and Iroquois Capital Management L.L.C., (ii) $3.0 million from Alpha Capital Anstalt and (iii) $2.0 million from The Hewlett Fund LP, each of whom is the beneficial owner of 5.0% or more of our Common Stock.

Stakeholder Impact

• Approval of the proposals could impact shareholders by potentially increasing the stock price and attracting more investors.
• Failure to approve the proposals could limit the company's ability to raise capital and pursue strategic opportunities, potentially harming shareholder value.
• Employees may be affected by the company's ability to offer equity incentives.

Next Steps

• Stockholders to vote on the proposals at the Annual Meeting on May 19, 2025.
• The Board will determine whether to implement the reverse stock split and at what ratio, if the proposal is approved.
• The Board will file the Share Increase Amendment with the office of the Secretary of State of Delaware, if the proposal is approved.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Share Increase, Reverse Stock Split, Director Election, Auditor Ratification, AYRO, Stockholders